Sna-60-367-18
| Internal ID | 5b2b26c5-9aef-411a-a2a0-c6e255f57563 |
| Taxonomy | Organic acids and derivatives > Peptidomimetics > Depsipeptides > Cyclic depsipeptides |
| IUPAC Name | 5-[[5-amino-1-[[10-(3-amino-3-oxopropyl)-4-butan-2-yl-22-(2-carboxyethyl)-25-(1-hydroxyethyl)-7-[(4-hydroxyphenyl)methyl]-3,6,9,12,18,21,24,27-octaoxo-19-propan-2-yl-2-oxa-5,8,11,17,20,23,26-heptazatricyclo[28.2.2.013,17]tetratriaconta-1(33),30(34),31-trien-28-yl]amino]-1-oxopentan-2-yl]amino]-4-(hexadecanoylamino)-5-oxopentanoic acid |
| SMILES (Canonical) | CCCCCCCCCCCCCCCC(=O)NC(CCC(=O)O)C(=O)NC(CCCN)C(=O)NC1CC2=CC=C(C=C2)OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C3CCCN3C(=O)C(NC(=O)C(NC(=O)C(NC1=O)C(C)O)CCC(=O)O)C(C)C)CCC(=O)N)CC4=CC=C(C=C4)O)C(C)CC |
| SMILES (Isomeric) | CCCCCCCCCCCCCCCC(=O)NC(CCC(=O)O)C(=O)NC(CCCN)C(=O)NC1CC2=CC=C(C=C2)OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C3CCCN3C(=O)C(NC(=O)C(NC(=O)C(NC1=O)C(C)O)CCC(=O)O)C(C)C)CCC(=O)N)CC4=CC=C(C=C4)O)C(C)CC |
| InChI | InChI=1S/C74H114N12O19/c1-7-9-10-11-12-13-14-15-16-17-18-19-20-25-59(90)77-52(35-38-60(91)92)66(96)78-51(23-21-40-75)65(95)81-56-43-48-28-32-50(33-29-48)105-74(104)63(45(5)8-2)84-69(99)55(42-47-26-30-49(88)31-27-47)82-67(97)53(34-37-58(76)89)79-71(101)57-24-22-41-86(57)73(103)62(44(3)4)83-68(98)54(36-39-61(93)94)80-72(102)64(46(6)87)85-70(56)100/h26-33,44-46,51-57,62-64,87-88H,7-25,34-43,75H2,1-6H3,(H2,76,89)(H,77,90)(H,78,96)(H,79,101)(H,80,102)(H,81,95)(H,82,97)(H,83,98)(H,84,99)(H,85,100)(H,91,92)(H,93,94) |
| InChI Key | NGDNPQANYNDBAJ-UHFFFAOYSA-N |
| Popularity | 0 references in papers |
| Molecular Formula | C74H114N12O19 |
| Molecular Weight | 1475.80 g/mol |
| Exact Mass | 1474.83231945 g/mol |
| Topological Polar Surface Area (TPSA) | 493.00 Ų |
| XlogP | 4.80 |
| Atomic LogP (AlogP) | 2.75 |
| H-Bond Acceptor | 18 |
| H-Bond Donor | 15 |
| Rotatable Bonds | 37 |
| AKOS040735458 |
| SNA 60-367-18 |
| SNA-60-367-18 |
| 5-[[5-Amino-1-[[10-(3-amino-3-oxopropyl)-4-butan-2-yl-22-(2-carboxyethyl)-25-(1-hydroxyethyl)-7-[(4-hydroxyphenyl)methyl]-3,6,9,12,18,21,24,27-octaoxo-19-propan-2-yl-2-oxa-5,8,11,17,20,23,26-heptazatricyclo[28.2.2.013,17]tetratriaconta-1(33),30(34),31-trien-28-yl]amino]-1-oxopentan-2-yl]amino]-4-(hexadecanoylamino)-5-oxopentanoic acid |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.6101 | 61.01% |
| Caco-2 | - | 0.8630 | 86.30% |
| Blood Brain Barrier | - | 0.9750 | 97.50% |
| Human oral bioavailability | - | 0.7286 | 72.86% |
| Subcellular localzation | Lysosomes | 0.5479 | 54.79% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8317 | 83.17% |
| OATP1B3 inhibitior | + | 0.9264 | 92.64% |
| MATE1 inhibitior | - | 0.8400 | 84.00% |
| OCT2 inhibitior | - | 0.9000 | 90.00% |
| BSEP inhibitior | + | 0.9534 | 95.34% |
| P-glycoprotein inhibitior | + | 0.7421 | 74.21% |
| P-glycoprotein substrate | + | 0.8871 | 88.71% |
| CYP3A4 substrate | + | 0.7425 | 74.25% |
| CYP2C9 substrate | - | 0.5968 | 59.68% |
| CYP2D6 substrate | - | 0.7892 | 78.92% |
| CYP3A4 inhibition | - | 0.7161 | 71.61% |
| CYP2C9 inhibition | - | 0.9069 | 90.69% |
| CYP2C19 inhibition | - | 0.8657 | 86.57% |
| CYP2D6 inhibition | - | 0.8535 | 85.35% |
| CYP1A2 inhibition | - | 0.9594 | 95.94% |
| CYP2C8 inhibition | + | 0.8064 | 80.64% |
| CYP inhibitory promiscuity | - | 0.9317 | 93.17% |
| UGT catelyzed | + | 0.6000 | 60.00% |
| Carcinogenicity (binary) | - | 0.8800 | 88.00% |
| Carcinogenicity (trinary) | Non-required | 0.5960 | 59.60% |
| Eye corrosion | - | 0.9892 | 98.92% |
| Eye irritation | - | 0.8958 | 89.58% |
| Skin irritation | - | 0.7890 | 78.90% |
| Skin corrosion | - | 0.9292 | 92.92% |
| Ames mutagenesis | - | 0.6537 | 65.37% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7069 | 70.69% |
| Micronuclear | + | 0.8700 | 87.00% |
| Hepatotoxicity | - | 0.5448 | 54.48% |
| skin sensitisation | - | 0.8829 | 88.29% |
| Respiratory toxicity | + | 0.7778 | 77.78% |
| Reproductive toxicity | + | 0.9333 | 93.33% |
| Mitochondrial toxicity | + | 0.9375 | 93.75% |
| Nephrotoxicity | + | 0.5308 | 53.08% |
| Acute Oral Toxicity (c) | III | 0.5632 | 56.32% |
| Estrogen receptor binding | + | 0.6146 | 61.46% |
| Androgen receptor binding | + | 0.7261 | 72.61% |
| Thyroid receptor binding | + | 0.6515 | 65.15% |
| Glucocorticoid receptor binding | + | 0.7573 | 75.73% |
| Aromatase binding | + | 0.7404 | 74.04% |
| PPAR gamma | + | 0.7651 | 76.51% |
| Honey bee toxicity | - | 0.6986 | 69.86% |
| Biodegradation | - | 0.8500 | 85.00% |
| Crustacea aquatic toxicity | + | 0.5700 | 57.00% |
| Fish aquatic toxicity | + | 0.9596 | 95.96% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.97% | 98.95% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.49% | 96.09% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 99.25% | 94.45% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 99.12% | 99.17% |
| CHEMBL3837 | P07711 | Cathepsin L | 99.11% | 96.61% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 98.63% | 91.11% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 98.44% | 82.38% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 96.86% | 90.08% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 96.61% | 90.71% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 96.19% | 93.00% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 96.03% | 97.09% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 95.84% | 95.89% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 95.47% | 95.00% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 95.22% | 93.56% |
| CHEMBL236 | P41143 | Delta opioid receptor | 94.52% | 99.35% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 93.94% | 95.50% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 93.08% | 97.64% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 92.80% | 100.00% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 92.44% | 95.89% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 92.15% | 94.66% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 91.77% | 96.67% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 91.21% | 97.14% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 91.14% | 96.47% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 90.85% | 96.90% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 90.71% | 94.45% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 90.24% | 100.00% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 89.29% | 95.56% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 89.27% | 96.11% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 89.25% | 98.05% |
| CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 88.83% | 92.88% |
| CHEMBL1293287 | P14735 | Insulin-degrading enzyme | 88.69% | 88.10% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 88.11% | 85.14% |
| CHEMBL5852 | Q96P65 | Pyroglutamylated RFamide peptide receptor | 87.87% | 85.00% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 87.53% | 98.33% |
| CHEMBL3524 | P56524 | Histone deacetylase 4 | 87.51% | 92.97% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 86.84% | 98.94% |
| CHEMBL1902 | P62942 | FK506-binding protein 1A | 86.63% | 97.05% |
| CHEMBL1937 | Q92769 | Histone deacetylase 2 | 86.30% | 94.75% |
| CHEMBL2001 | Q9H244 | Purinergic receptor P2Y12 | 86.02% | 96.00% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 85.85% | 89.50% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 85.62% | 97.25% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 85.60% | 90.20% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 85.09% | 82.69% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 84.32% | 97.23% |
| CHEMBL5255 | O00206 | Toll-like receptor 4 | 83.49% | 92.50% |
| CHEMBL4633 | P22001 | Voltage-gated potassium channel subunit Kv1.3 | 83.43% | 100.00% |
| CHEMBL1075317 | P61964 | WD repeat-containing protein 5 | 82.92% | 96.33% |
| CHEMBL4101 | P17612 | cAMP-dependent protein kinase alpha-catalytic subunit | 82.79% | 82.86% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 82.36% | 100.00% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 82.17% | 100.00% |
| CHEMBL1801 | P00747 | Plasminogen | 81.95% | 92.44% |
| CHEMBL5203 | P33316 | dUTP pyrophosphatase | 81.57% | 99.18% |
| CHEMBL4769 | O95749 | Geranylgeranyl pyrophosphate synthetase | 81.42% | 92.08% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 80.91% | 91.19% |
| CHEMBL242 | Q92731 | Estrogen receptor beta | 80.53% | 98.35% |
| CHEMBL5966 | P55899 | IgG receptor FcRn large subunit p51 | 80.12% | 90.93% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 85352709 |
| LOTUS | LTS0064079 |
| wikiData | Q105178841 |